Birch Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Birch Capital Management's RMD Position: Q2 2026 in Review
Birch Capital Management reduced its ResMed (RMD) stake by 1.4% in Q2 2026, selling an estimated $76.3K and leaving 26,641 shares worth $5.19M. The position accounts for 2.54% of the portfolio, ranked #16.
Birch Capital Management first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.73M in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Birch Capital Management held 26,641 shares of ResMed worth $5.19M as of Q2 2026.
- Birch Capital Management sold 368 ResMed shares in Q2 2026, an estimated $76.3K.
- ResMed made up 2.54% of Birch Capital Management's portfolio in Q2 2026, its #16 holding.
- Birch Capital Management first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
- Birch Capital Management's ResMed position peaked at $9.73M in Q3 2025.
- 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Birch Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.